Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Cytek Biosciences (CTKB) Receivables Refunds (2020 - 2021)

Cytek Biosciences (CTKB) has disclosed Receivables Refunds for 2 consecutive years, with $1.4 million as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Receivables Refunds changed N/A year-over-year to $1.4 million, compared with a TTM value of $1.4 million through Sep 2021, changed N/A, and an annual FY2020 reading of $1.1 million, changed N/A over the prior year.
  • Receivables Refunds was $1.4 million for Q3 2021 at Cytek Biosciences, down from $1.4 million in the prior quarter.
  • Across five years, Receivables Refunds topped out at $1.4 million in Q2 2021 and bottomed at $1.1 million in Q4 2020.